4.3 Article

Myelination in mouse dorsal root ganglion/Schwann cell cocultures

Journal

MOLECULAR AND CELLULAR NEUROSCIENCE
Volume 37, Issue 3, Pages 568-578

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mcn.2007.12.005

Keywords

mouse; myelin; peripheral nervous system; culture; Schwann cell

Categories

Ask authors/readers for more resources

The established protocols for in vitro studies of peripheral nerve myelination with rat embryonic dorsal root ganglia (DRG) and postnatal Schwann cell cocultures do not work with mouse cells. Consequently, the full potential of this model, which would allow to perform cell type-specific, mixed genotype cocultures without crossbreeding the animals, cannot be exploited. We determined the conditions required to promote full myelination in cocultures of prepurified mouse embryonic DRG and neonatal Schwann cells, and present a method which consistently yields 50-200 mature myelin sheaths/culture. Causes for the failure of the existing protocols to yield satisfactory results with mouse cells fell into three categories: the lack of adherent support provided by the substratum, growth factor and hormone deficiencies, and the high serum content of the media. For optimal results, mouse cocultures require a 3-dimensional substratum, a myelination-promoting culture medium containing pituitary extract, N2 supplement and forskolin, and a low serum concentration. (c) 2007 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Circulating free DNA in the plasma of individuals with neurofibromatosis type 1

Roope A. Kallionpaa, Kaisa Ahramo, Marianna Aaltonen, Paula Pennanen, Juha Peltonen, Sirkku Peltonen

Summary: The study investigated the levels of circulating free plasma DNA (cfDNA) in NF1 patients and healthy controls, finding that NF1 may have a limited impact on cfDNA levels, likely not affecting the use of cfDNA-based assays.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)

Article Genetics & Heredity

A rare disease and education: Neurofibromatosis type 1 decreases educational attainment

Edvard Johansson, Roope A. Kallionpaa, Petri Bockerman, Juha Peltonen, Sirkku Peltonen

Summary: NF1 is associated with reduced educational attainment, with individuals more likely to pursue vocational education. History of cancer and developmental disorders are major predictors of lack of secondary education. NF1 decreases the attainment of Bachelor's and Master's degrees.

CLINICAL GENETICS (2021)

Article Biochemistry & Molecular Biology

Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player

Paula Pennanen, Roope A. Kallionpaa, Sirkku Peltonen, Liisa Nissinen, Veli-Matti Kahari, Eetu Heerva, Juha Peltonen

Summary: This study evaluated the roles of various signaling pathways in human osteoclast differentiation and found that inhibiting most pathways decreased osteoclast numbers and disrupted morphology, with p38 inhibition unexpectedly increasing osteoclast numbers. The Ras inhibitor FTS had differing effects on control and NF1 samples, while MEK, PI3K, and mTOR inhibition reduced NF1 osteoclast numbers significantly. Overall, the results highlight the complexity of osteoclastogenesis regulation by multiple pathways and underscore the differences between murine and human findings in this process.

MOLECULAR BIOLOGY REPORTS (2021)

Article Dermatology

Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1

Roope A. Kallionpaa, Kaisa Ahramo, Eija Martikkala, Elnaz Fazeli, Pekka Haapaniemi, Anne Rokka, Ilmo Leivo, Ilkka T. Harvima, Juha Peltonen, Sirkku Peltonen

Summary: The results highlight the abundance of mast cells in cNFs and that their number and subtypes clearly differ from those previously reported in unaffected skin.

DERMATOLOGY (2022)

Article Allergy

Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis

Eeva Sliz, Laura Huilaja, Anu Pasanen, Triin Laisk, Ene Reimann, Reedik Magi, Katariina Hannula-Jouppi, Sirkku Peltonen, Teea Salmi, Leena Koulu, Kaisa Tasanen, Johannes Kettunen

Summary: This study aimed to gain a better understanding of the genetic contribution to atopic dermatitis (AD) risk by utilizing biobank resources. Through a genome-wide meta-analysis, the researchers identified 30 loci associated with AD, including 5 novel loci. Two of the novel loci were found to have missense mutations in genes crucial to the integrity and strength of the epidermis. These findings provide insights into novel genetic pathways involved in AD pathophysiology and potential opportunities for future treatment strategies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Genetics & Heredity

Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience

Sirkku Peltonen, Arnaud Jannic, Pierre Wolkenstein

Summary: Cutaneous neurofibromas are a hallmark of neurofibromatosis 1 and can cause pain and itch for patients. The use of CO2 laser for cNF removal has been shown to be a feasible treatment option in clinical practice.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)

Article Genetics & Heredity

The rare disease neurofibromatosis 1 as a source of hereditary economic inequality: Evidence from Finland

Edvard Johansson, Roope A. Kallionpaa, Petri Bockerman, Sirkku Peltonen, Juha Peltonen

Summary: This study investigated the impact of neurofibromatosis 1 (NF1) on economic well-being and found that individuals with NF1 had worse economic outcomes compared to those without NF1. The effect of NF1 on economic well-being was partially explained by factors such as low education, increased morbidity, and reduced labor market participation. NF1 had a larger negative effect on income from work than on total income, indicating partial compensation from the Finnish social security system. The study also found that NF1 had a greater impact on economic inequality for men than for women.

GENETICS IN MEDICINE (2022)

Article Oncology

Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma

Pegah Rahmati Nezhad, Pilvi Riihilae, Jaakko S. Knuutila, Kristina Viiklepp, Sirkku Peltonen, Markku Kallajoki, Seppo Meri, Liisa Nissinen, Veli-Matti Kahari

Summary: The most common metastatic skin cancer, cutaneous squamous cell carcinoma (cSCC), is growing worldwide, and there are no biomarkers or therapeutic targets for high-risk cSCCs. Recent studies have identified the essential role of autocrine complement synthesis in cSCC progression. This study evaluates the role of complement Factor D (FD), the rate-limiting enzyme of the alternative complement pathway, in cSCC development. The results identify FD as a novel biomarker and potential therapeutic target for cSCC, and propose the small-molecule FD inhibitor Danicopan as a highly specific drug candidate in the therapy of advanced cSCC. Discovery of complement-associated molecular markers for cSCC progression would improve diagnosis, classification, prognostication, and targeted therapy of cSCC and its precursors in the future.

CANCERS (2022)

Article Neurosciences

Analysis of human brain tissue derived from DBS surgery

Salla M. Kangas, Jaakko Teppo, Maija J. Lahtinen, Anu Suoranta, Bishwa Ghimire, Pirkko Mattila, Johanna Uusimaa, Markku Varjosalo, Jani Katisko, Reetta Hinttala

Summary: This study presents an improved method for collecting fresh brain tissue samples from surgical instruments used in deep brain stimulation (DBS) procedures. The collected tissues were used for transcriptomic and proteomic analyses. The results indicate that the surgical instruments retain sufficient brain material for protein and gene expression studies, and the approach is robust and reproducible.

TRANSLATIONAL NEURODEGENERATION (2022)

Article Pediatrics

Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center

Paula L. Keskitalo, Salla M. Kangas, Sirja Sard, Tytti Pokka, Virpi Glumoff, Petri Kulmala, Paula Vahasalo

Summary: This study found that MRP8/14 levels can predict disease progression in patients with new-onset JIA, and P-MRP8/14 may be more effective in assessing disease activity compared to S-MRP8/14.

PEDIATRIC RHEUMATOLOGY (2022)

Article Dermatology

Porokeratosis is one of the most common genodermatoses and is associated with an increased risk of keratinocyte cancer and melanoma

Rahime Inci, Theofanis Zagoras, Despoina Kantere, Peter Holmstrom, Martin Gillstedt, Sam Polesie, Sirkku Peltonen

Summary: Porokeratosis is a common genodermatosis that is associated with an increased risk of skin cancer.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Neurosciences

Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson's disease

Dani Flinkman, Ye Hong, Jelena Gnjatovic, Prasannakumar Deshpande, Zsuzsanna Ortutay, Sirkku Peltonen, Valtteri Kaasinen, Peter James, Eleanor Coffey

Summary: Deficits in protein synthesis are associated with Parkinson's disease (PD). We conducted a study to identify the specific proteins affected and differences in synthesis between sporadic and LRRK2-G2019S PD patients. Through proteomic analysis, we found that regulators of endo-lysosomal sorting, mRNA processing, and components of the translation machinery were consistently low in both sporadic and LRRK2-G2019S PD patients. This study provides valuable insights into the dysregulation of proteostasis in PD.

NPJ PARKINSONS DISEASE (2023)

Article Biochemistry & Molecular Biology

The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland

Roope A. Kallionpaa, Edvard Johansson, Petri Bockerman, Juha Peltonen, Sirkku Peltonen

Summary: Neurofibromatosis 1 (NF1) is a multisystem disorder associated with a high risk for cancer, behavioral and cognitive deficits, low educational attainment, and decreased income. This study analyzed labor market participation in individuals with NF1 in Finland and found that they had significantly fewer working days per year, higher unemployment, and more sickness absence compared to a control group. The causes of sickness absence were consistent with the morbidity profile of NF1. Overall, NF1 significantly interferes with labor market participation through both unemployment and morbidity.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

No Data Available